From meeting with the president and CEO of Renton, Wash.-based Providence to growing its healthcare team, here are seven of OpenAI’s healthcare moves as reported by Becker’s since February:
Editor’s note: This article was updated Nov. 13 and will continue to be updated with the latest news.
- Business Insider reported that OpenAI is exploring whether to expand into consumer health applications. The tech company is discussing products such as a generative AI-powered personal health assistant and a health data aggregator.
- OpenAI’s newly named nonprofit arm, The OpenAI Foundation, announced that it will dedicate $25 billion to health and curing diseases and technical solutions to AI resilience.
- In September, Oracle announced plans to embed OpenAI technology into its patient portal.
- In August, OpenAI added two new members to its healthcare team. The AI company appointed Ashley Alexander as its new vice president of health products and Nate Gross, MD, to lead its healthcare strategy.
- On Aug. 7, OpenAI released GPT-5, its latest AI model, with improvements in handling health-related questions, according to the company. The model outperforms earlier versions on HealthBench, a benchmark based on real-world medical scenarios and physician-defined standards. GPT-5 is designed to act as a thought partner, helping people better understand their health, ask informed questions, and prepare for discussions with healthcare providers.
- In May, OpenAI introduced HealthBench, a new evaluation framework to assess how AI systems perform in healthcare settings. The tool evaluates AI performance in realistic healthcare scenarios based on priorities identified by physicians.
- In February, Erik Wexler, president and CEO of Providence, met with OpenAI to explore the future of AI in healthcare.
